Renin-Angiotensin System Inhibitors Suppress the Growth of Leukemia Cells

CONCLUSION: RAS inhibitors can be repurposed as molecular-targeted drugs for leukemia. However, the concentrations of the inhibitors were much higher than those in the plasma of patients with hypertension. Therefore, further investigation is required for their clinical use.PMID:38423665 | DOI:10.21873/anticanres.16913

Source: Cell Research - February 29, 2024 Category: Cytology Authors: Mai Itoh Shun Sasaki Shuji Tohda Source Type: research